# Haukeland University Hospital: Phase 2 study in Prostate Cancer, Prostate Cancer Locally Advanced (191 participants)

**Score:** 70/100

| Field | Value |
|---|---|
| Sponsor | Haukeland University Hospital |
| Sponsor type | Academic and hospital |
| Study | Hypofractionated Radiotherapy With Magnetic Resonance Imaging-Guided Focal Boost and Pelvic Irradiation in High-Risk Prostate Cancer |
| NCT ID | NCT07900555 |
| Phase | Phase 2 |
| Status | completed |
| Conditions | Prostate Cancer; Prostate Cancer Locally Advanced; Prostatic Neoplams |
| Intervention types | radiation, drug |
| Target enrollment | 191 |
| Site countries | Norway |
| Posted | 2026-10-28 |
| Planned start | 2014-02-24 |
| Event | Newly registered study |
| Event date | 2026-10-28 |

## Why this score
- Posted in the last two weeks.
- Phase 2: multi-site, larger budget.
- 191 participants planned.

Source: ClinicalTrials.gov (U.S. National Library of Medicine) API v2 (https://clinicaltrials.gov/study/NCT07900555). Last refreshed: 2026-11-05T08:46:16.625Z.
From public ClinicalTrials.gov registrations. Sponsor and study level only: we never list investigators, contacts or participants. A registration describes a planned study and can change. Status changes are read from each study's current status, actual dates and latest posted update, not a full change history, so an update can be a correction rather than a new change. Verify on ClinicalTrials.gov.